Does elevated total bilirubin in hereditary spherocytosis reflect increased heme breakdown from ongoing hemolysis?

Hereditary spherocytosis (HS) is a genetic disorder characterized by defects in red blood cell (RBC) membrane proteins, such as spectrin and ankyrin. These defects lead to the formation of rigid, spherical cells (spherocytes) that are selectively trapped and destroyed in the spleen.

Clinical evidence

• Hemolytic Rate and Bilirubin: In patients with HS, serum total bilirubin levels are a reliable proxy for the rate of hemolysis. Clinical studies demonstrate that the degree of reticulocytosis (new RBC production) and the severity of anemia correlate strongly with elevated bilirubin levels.
• Resolution after Splenectomy: The causal link between splenic RBC destruction and bilirubin elevation is most clearly seen following splenectomy. By removing the primary site of hemolysis, the procedure significantly reduces the heme load, typically resulting in the normalization or substantial decrease of serum bilirubin levels.
• Gilbert Syndrome Interaction: While hemolysis is the primary driver, co-inheritance of the UGT1A1 promoter polymorphism (Gilbert syndrome) can markedly amplify hyperbilirubinemia. In HS patients, the presence of this polymorphism is associated with higher bilirubin levels and an increased incidence of pigment gallstones (cholelithiasis).

Mechanistic explanations

• Splenic Sequestration: Spherocytes are poorly deformable, making them unable to pass through the narrow slits in the splenic cords. This leads to sequestration and destruction by splenic macrophages (extravascular hemolysis).
• Heme Catabolic Pathway: The destruction of RBCs releases hemoglobin, which is catabolized within macrophages. The enzyme heme oxygenase-1 (HO-1) breaks down heme into iron, carbon monoxide, and biliverdin. Biliverdin is then rapidly reduced to unconjugated bilirubin by biliverdin reductase.
• Enzymatic Saturation: The massive flux of heme from chronic hemolysis can saturate the liver's conjugation capacity (mediated by the enzyme UGT1A1), leading to an accumulation of unconjugated bilirubin in the systemic circulation.

Safety and clinical implications

• Pigment Gallstones: Chronic elevations in bilirubin lead to an increased concentration of bilirubin in the bile. This can precipitate with calcium to form calcium bilirubinate stones (pigment gallstones). Up to 50% of HS patients may develop gallstones, often starting in childhood or early adulthood.
• Monitoring: For a 42-year-old male with HS, monitoring total and indirect bilirubin levels is essential for tracking hemolytic activity and assessing the risk of biliary complications.

Bottom line

In hereditary spherocytosis, elevated total bilirubin is a direct biomarker of increased heme catabolism resulting from ongoing extravascular hemolysis. This process is driven by the splenic destruction of defective red blood cells and is a primary risk factor for the development of pigment gallstones.